The Use of the Biomarker Procalcitonin in Pediatric Cardiovascular Disorders
2019
Purpose of Review We highlight the recent data investigating the use of the biomarker
procalcitonin(PCT) in several clinical scenarios involving children with cardiovascular disorders. The diagnostic, therapeutic, and prognostic uses of PCT are discussed.
Keywords:
-
Correction
-
Source
-
Cite
-
Save
54
References
0
Citations
NaN
KQI